Get the Stockscreener App
0.3671
0.60%
-0.0022
After Hours:
.36
-0.0071
-1.93%
Scienture Holdings Inc stock is traded at $0.3671, with a volume of 481.15K.
It is down -0.60% in the last 24 hours and up +1.92% over the past month.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
See More
Previous Close:
$0.3693
Open:
$0.3616
24h Volume:
481.15K
Relative Volume:
0.39
Market Cap:
$14.92M
Revenue:
$656.60K
Net Income/Loss:
$-16.79M
P/E Ratio:
-0.3417
EPS:
-1.0743
Net Cash Flow:
$-11.12M
1W Performance:
-11.75%
1M Performance:
+1.92%
6M Performance:
-26.58%
1Y Performance:
-81.55%
1-Day Range:
$0.3478
$0.3826
1-Week Range:
$0.3478
$0.4151
52-Week Range:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings Inc
Sector
Industry
Phone
(800) 261 0281
Address
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, MEDS, POM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.3671 | 15.00M | 656.60K | -16.79M | -11.12M | -1.0743 |
HITI
High Tide Inc
|
2.13 | 188.92M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.97 | 42.53M | 179.02M | -57.29M | -33.01M | -2.7487 |
MEDS
Trxade Health Inc
|
3.12 | 7.97M | 7.15M | 4.03M | -11.33M | -5.40 |
POM
Pomdoctor Ltd Adr
|
0.7211 | 5.29M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc Stock (SCNX) Latest News
Scienture Holdings Inc (SCNX) Cash Flow - TradingKey
When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable? - simplywall.st
Scienture Holdings Inc (SCNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scienture Holdings Inc (SCNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value to EBITDA forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
TradingKey - TradingKey
Scienture Holdings Inc (SCNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCNX|Scienture Holdings Inc|Price:0.370|Chg%:+0.001 - TradingKey
Scienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scienture Holdings Inc (SCNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SCNX|Scienture Holdings Inc|Price:0.372|Chg%:+0.003 - TradingKey
SCNX|Scienture Holdings Inc|Price:0.357|Chg%:-0.012 - TradingKey
Scienture Holdings Inc (SCNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DataMEDS AI Intends to Target GLP-1 Muscle Loss and Long COVID - Stock Titan
SCNX SEC FilingsScienture Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Scienture completes manufacturing for naloxone spray launch By Investing.com - Investing.com Nigeria
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionConsensus Beat Rate - dars.gov.et
$Scienture Holdings (SCNX.US)$ - Moomoo
Scienture Holdings stock jumps over 20% pre-market: Here's why - MSN
Scienture Holdings Company Profile & Introduction - Moomoo
Maxim Group Maintains Scienture Holdings(SCNX.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX) - The Globe and Mail
Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why - Sahm
Scienture Holdings (SCNX) Registration filing Summary - Quartr
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Scienture Holdings, Inc. Completes Manufacturing of Commercial Launch Inventory and Begins Shipments of Rezenopy Nasal Spray 10 Mg to U.S. Pharmaceutical Wholesalers - marketscreener.com
Scienture (SCNX) Prepares for Rezonopy Nasal Spray Launch - GuruFocus
Discover the top movers in Thursday's pre-market session. - ChartMill
Scienture completes manufacturing for naloxone spray launch - Investing.com
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers - marketscreener.com
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY (Naloxone Hydrochloride) to Wholesalers - Moomoo
Scienture readies highest-dose naloxone spray for August sale - Stock Titan
Scienture Holdings (SCNX) Slips 4% as Stock Tests Key Support Near $0.31Daily Profile - dars.gov.et
Scienture secures $11M debt financing for product launches - Investing.com
SCNX Q1 2026 Earnings: Significant EPS Beat Amid Pre-Revenue Stage as Scienture Outperforms Analyst ExpectationsEPS Surprise History - dars.gov.et
SCNX Q1 2026 Earnings: EPS Beat Narrower Losses, Shares SlideEarnings Beat Streak - dars.gov.et
Price to sales forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Price to book forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Price to earnings forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Scienture Holdings, Inc. Actuals & Estimates (NASDAQ:SCNX) - TradingView
SCNX Q1 2026 Earnings: EPS Surprise of 64.35% Amid Revenue Silence; Stock Declines 1.42%Quarterly Earnings - dars.gov.et
SCNX Forecast — Price Target — Prediction for 2027 - TradingView
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-than-Expected Loss Fails to Lift Shares - dars.gov.et
Scienture Holdings Inc (SCNX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Scienture stock rises after adding 12.5M covered lives for Arbli - Investing.com Australia
Scienture stock rises after adding 12.5M covered lives for Arbli By Investing.com - Investing.com Australia
Scienture (SCNX) Advances Commercialization of Arbli - GuruFocus
Scienture expands payor coverage for Arbli by 12.5M lives - Investing.com
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide - marketscreener.com
Scienture Holdings Inc (SCNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scienture Holdings Inc (SCNX) Institutional Confidence - TradingKey
Scienture Holdings Inc Stock (SCNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.58%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):